Genetic forms of neurohypophyseal diabetes insipidus.


Journal

Best practice & research. Clinical endocrinology & metabolism
ISSN: 1878-1594
Titre abrégé: Best Pract Res Clin Endocrinol Metab
Pays: Netherlands
ID NLM: 101120682

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 28 7 2020
medline: 16 3 2021
entrez: 27 7 2020
Statut: ppublish

Résumé

In the majority of cases, hereditary neurohypophyseal diabetes insipidus (DI) is a monogenic disorder caused by mutations in the AVP gene. Dominant transmission is by far the most common form. In these patients, symptoms develop gradually at various ages during childhood, progressing with complete penetrance to polyuria and polydipsia that is usually severe. In autosomal dominant neurohypophyseal DI (ADNDI), the mutant prohormone is folding deficient and consequently retained in the ER, where it forms amyloid-like fibrillar aggregates. Degradation by proteasomes occurs, but their clearance capacity appears to be insufficient. Postmortem studies in affected individuals suggest a neurodegenerative process confined to vasopressinergic neurons. Other forms of genetic neurohypophyseal DI include the very rare autosomal recessive type, also caused by mutations in the AVP gene, and complex multiorgan disorders, such as Wolfram syndrome. In all individuals where a congenital form of DI is suspected, including nephrogenic types, genetic analysis should be performed.

Identifiants

pubmed: 32712149
pii: S1521-690X(20)30059-2
doi: 10.1016/j.beem.2020.101432
pii:
doi:

Substances chimiques

AVP protein, human 0
Neurophysins 0
Protein Precursors 0
Vasopressins 11000-17-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101432

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Martin Spiess (M)

University of Basel, Biozentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland. Electronic address: martin.spiess@unibas.ch.

Nicole Beuret (N)

University of Basel, Biozentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland. Electronic address: nicole.beuret@unibas.ch.

Jonas Rutishauser (J)

University of Basel, Biozentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland; Kantonsspital Baden, Clinical Trial Unit, Im Ergel 1, CH-5405 Baden, Switzerland. Electronic address: j.rutishauser@unibas.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH